175 related articles for article (PubMed ID: 38504847)
1. Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma.
Pothuri VS; Hogg GD; Conant L; Borcherding N; James CA; Mudd J; Williams G; Seo YD; Hawkins WG; Pillarisetty VG; DeNardo DG; Fields RC
Oncoimmunology; 2024; 13(1):2320411. PubMed ID: 38504847
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
3. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.
Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M
Front Immunol; 2021; 12():730746. PubMed ID: 34630409
[TBL] [Abstract][Full Text] [Related]
4. High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma.
Pan Y; Gao J; Lin J; Ma Y; Hou Z; Lin Y; Wen S; Pan M; Lu F; Huang H
Front Endocrinol (Lausanne); 2023; 14():1181538. PubMed ID: 37347110
[TBL] [Abstract][Full Text] [Related]
5. Antigen/HLA-agnostic strategies for Characterizing Tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application.
Wang X; Dai Z; Lin X; Zou X; Wang R; Tasiheng Y; Yan Y; Ma M; Chen Y; Cheng H; Liu C; Yu X
Cancer Lett; 2024 Apr; 588():216741. PubMed ID: 38395378
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome-based identification of tumor-reactive and bystander CD8
Meng Z; Rodriguez Ehrenfried A; Tan CL; Steffens LK; Kehm H; Zens S; Lauenstein C; Paul A; Schwab M; Förster JD; Salek M; Riemer AB; Wu H; Eckert C; Leonhardt CS; Strobel O; Volkmar M; Poschke I; Offringa R
Sci Transl Med; 2023 Nov; 15(722):eadh9562. PubMed ID: 37967201
[TBL] [Abstract][Full Text] [Related]
7. Time-spatial analysis of T cell receptor repertoire in esophageal squamous cell carcinoma patients treated with combined radiotherapy and PD-1 blockade.
Yan C; Ma X; Guo Z; Wei X; Han D; Zhang T; Chen X; Cao F; Dong J; Zhao G; Gao X; Wang T; Jiang Y; Wang P; Pang Q; Zhang W
Oncoimmunology; 2022; 11(1):2025668. PubMed ID: 35036077
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy.
Schina A; Sztupinszki Z; Marie Svane I; Szallasi Z; Jönsson G; Donia M
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604641
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
[TBL] [Abstract][Full Text] [Related]
10. Low intratumoral regulatory T cells and high peritumoral CD8(+) T cells relate to long-term survival in patients with pancreatic ductal adenocarcinoma after pancreatectomy.
Liu L; Zhao G; Wu W; Rong Y; Jin D; Wang D; Lou W; Qin X
Cancer Immunol Immunother; 2016 Jan; 65(1):73-82. PubMed ID: 26646849
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma.
Hopkins AC; Yarchoan M; Durham JN; Yusko EC; Rytlewski JA; Robins HS; Laheru DA; Le DT; Lutz ER; Jaffee EM
JCI Insight; 2018 Jul; 3(13):. PubMed ID: 29997287
[TBL] [Abstract][Full Text] [Related]
12. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
[TBL] [Abstract][Full Text] [Related]
13. Global analysis of T-cell groups reveals immunological features and common antigen targets of digestive tract tumors.
Li X; Zhang Y; Guo S; Wu Z; Wang H; Huang Y; Wang Y; Qiu M; Lang J; Xiao Y; Zhu Y; Jin G; Hu L; Kong X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):129. PubMed ID: 38488909
[TBL] [Abstract][Full Text] [Related]
14. Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC.
Wang J; Zhang T; Li P; Gai J; Chen S; Espinoza G; Kung HC; Zhang R; Fujiwara K; Fu J; Yu J; Zheng L
Cancer Lett; 2023 Oct; 573():216366. PubMed ID: 37640197
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
16. In chronic infection, HIV gag-specific CD4+ T cell receptor diversity is higher than CD8+ T cell receptor diversity and is associated with less HIV quasispecies diversity.
Pilkinton MA; McDonnell WJ; Barnett L; Chopra A; Gangula R; White KD; Leary S; Currenti J; Gaudieri S; Mallal SA; Kalams SA
J Virol; 2021 Mar; 95(8):. PubMed ID: 33536169
[TBL] [Abstract][Full Text] [Related]
17. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
18. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
[TBL] [Abstract][Full Text] [Related]
19. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
Front Immunol; 2021; 12():643529. PubMed ID: 33679807
[No Abstract] [Full Text] [Related]
20. Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma.
Zheng H; Li Y; Zhao Y; Jiang A
Sci Rep; 2023 Mar; 13(1):3684. PubMed ID: 36878969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
